Characteristics | Total (n = 190) | Good prognosis group (n = 157) | Poor prognosis group (n = 33) | P |
---|---|---|---|---|
Gender (male, n, %) | 122 (64.2) | 102 (65.0) | 20 (60.6) | 0.635 |
Age, mean (± SD) | 70.389 ± 11.675 | 69.854 ± 11.201 | 72.939 ± 13.416 | 0.100 |
Vascular risk factors | Â | Â | Â | Â |
Smoking, n (%) | Â | Â | Â | Â |
 Yes | 51 (26.8) | 45 (28.7) | 6 (18.2) | 0.217 |
 No | 139 (73.2) | 112 (71.3) | 27 (81.8) | |
Drinking, n (%) | Â | Â | Â | Â |
 Yes | 28 (14.7) | 26 (16.6) | 2 (6.1) | 0.122 |
 No | 162 (85.3) | 131 (83.4) | 31 (93.9) | |
Diabetes, n (%) | Â | Â | Â | Â |
 Yes | 56 (29.5) | 46 (29.3) | 10 (30.3) | 0.908 |
 No | 134 (70.5) | 111 (70.7) | 23 (69.7) | |
Hypertension, n (%) | Â | Â | Â | Â |
 Yes | 128 (67.4) | 104 (66.2) | 24 (72.7) | 0.470 |
 No | 62 (32.6) | 53 (33.8) | 9 (27.3) | |
CHD, n (%) | Â | Â | Â | Â |
 Yes | 33 (17.4) | 25 (15.9) | 8 (24.2) | 0.252 |
 No | 157 (82.6) | 132 (84.1) | 25 (75.8) | |
AF, n (%) | Â | Â | Â | Â |
 Yes | 13 (6.8) | 11 (7.0) | 2 (6.1) | 0.845 |
 No | 177 (93.2) | 146 (93.0) | 31 (93.9) | |
Medical history | Â | Â | Â | Â |
Antiplatelet, n (%) | Â | Â | Â | Â |
 Yes | 44 (23.2) | 37 (23.6) | 7 (21.2) | 0.771 |
 No | 146 (76.8) | 120 (76.4) | 26 (78.8) | |
Statins, n (%) | Â | Â | Â | Â |
 Yes | 27 (14.2) | 22 (14.0) | 5 (15.2) | 0.865 |
 No | 163 (85.8) | 135 (86.0) | 28 (84.8) | |
Antihypertensive, n (%) | Â | Â | Â | Â |
 Yes | 117 (61.6) | 95 (60.5) | 22 (66.7) | 0.509 |
 No | 73 (38.4) | 62 (39.5) | 11 (33.3) | |
Hypoglycemic drug, n (%) | Â | Â | Â | Â |
 Yes | 52 (27.4) | 42 (26.8) | 10 (30.3) | 0.677 |
 No | 138 (72.6) | 115 (73.2) | 23 (69.7) | |
TOAST, n (%) | Â | Â | Â | Â |
LAA | 110 (57.9) | 92 (58.6) | 18 (54.5) | 0.029 |
CE | 25 (13.2) | 16 (10.2) | 9 (27.3) | |
SAO | 47 (24.7) | 43 (27.4) | 4 (12.1) | |
Unclassified | 8 (4.2) | 6 (3.8) | 2 (6.1) | |
OCSP, n (%) | Â | Â | Â | Â |
TACI | 34 (17.9) | 25 (15.9) | 9 (27.3) | 0.142 |
PACI | 63 (33.2) | 52 (33.1) | 11 (33.3) | |
LACI | 69 (36.3) | 62 (39.5) | 7 (21.2) | |
POCI | 24 (12.6) | 18 (11.5) | 6 (18.2) | |
Premorbid mRS, n (%) | Â | Â | Â | Â |
 0 | 55 (28.9) | 46 (29.3) | 9 (27.3) | < 0.001 |
 1 | 105 (55.3) | 86 (54.8) | 19 (57.6) |  |
 2 | 30 (15.8) | 25 (15.9) | 5 (15.2) |  |
NIHSS, median [IQR] | 4.000 [3.000,6.000] | 3.000 [2.000,5.000] | 7.000 [6.000,10.000] | < 0.001 |
SBP, mean (± SD) | 153.000 ± 23.806 | 152.204 ± 23.473 | 156.788 ± 24.983 | 0.317 |
DBP, mean (± SD) | 85.637 ± 14.868 | 84.701 ± 14.799 | 90.091 ± 14.381 | 0.056 |
Laboratory data | Â | Â | Â | Â |
LDL, median[IQR] | 2.750 [2.130,3.320] | 2.750 [2.130,3.320] | 2.810 [2.140,3.280] | 0.875 |
HDL, median [IQR] | 1.260 [1.080,1.500] | 1.260 [1.100,1.500] | 1.220 [1.060,1.390] | 0.458 |
RBG, median [IQR] | 6.180 [4.920,8.650] | 6.050 [4.910,7.680] | 7.420 [5.820,10.570] | 0.024 |
Lymphocyte, median [IQR] | 1.750 [1.260,2.350] | 1.830 [1.330,2.410] | 1.450 [0.930,1.770] | < 0.001 |
Monocyte, median [IQR] | 0.500 [0.390,0.660] | 0.510 [0.390,0.660] | 0.460 [0.400,0.670] | 0.946 |
Neutrophil, median [IQR] | 4.420 [3.290,5.550] | 4.320 [3.210,5.210] | 4.970 [4.130,8.250] | 0.001 |
Platelet, median [IQR] | 186.000 [153.000,224.000] | 188.000 [154.000,224.000] | 177.000 [153.000,209.000] | 0.372 |
MPV, median [IQR] | 10.300 [9.700,11.200] | 10.300 [9.700,11.200] | 10.400 [9.700,11.200] | 0.818 |
NLR, median [IQR] | 2.368 [1.596,3.893] | 2.159 [1.463,3.566] | 3.509 [2.838,7.237] | < 0.001 |
CRP, median [IQR] | 0.500 [0.500,1.740] | 0.500 [0.500,1.500] | 0.740 [0.500,4.260] | 0.107 |
Albumin, median [IQR] | 40.600 [37.700,42.900] | 40.400 [37.700,42.600] | 41.600 [37.700,43.500] | 0.176 |
IPI, median [IQR] | 0.047 [0.025,0.136] | 0.043 [0.023,0.113] | 0.109 [0.041,0.522] | < 0.001 |
SII, median [IQR] | 451.644 [293.248,715.759] | 413.571 [264.923,654.741] | 636.842 [461.159,1088.124] | < 0.001 |
SIRI, median [IQR] | 1.179 [0.732,2.036] | 1.083 [0.707,1.844] | 1.912 [1.298,3.726] | < 0.001 |